"Hemostatics" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Agents acting to arrest the flow of blood. Absorbable hemostatics arrest bleeding either by the formation of an artificial clot or by providing a mechanical matrix that facilitates clotting when applied directly to the bleeding surface. These agents function more at the capillary level and are not effective at stemming arterial or venous bleeding under any significant intravascular pressure.
Below are MeSH descriptors whose meaning is more general than "Hemostatics".
Below are MeSH descriptors whose meaning is more specific than "Hemostatics".
This graph shows the total number of publications written about "Hemostatics" by people in Harvard Catalyst Profiles by year, and whether "Hemostatics" was a major or minor topic of these publication.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 1 | 0 | 1 |
| 1996 | 1 | 1 | 2 |
| 1997 | 0 | 1 | 1 |
| 1998 | 3 | 0 | 3 |
| 1999 | 0 | 2 | 2 |
| 2000 | 1 | 2 | 3 |
| 2001 | 4 | 3 | 7 |
| 2002 | 1 | 3 | 4 |
| 2003 | 3 | 1 | 4 |
| 2004 | 3 | 0 | 3 |
| 2005 | 3 | 0 | 3 |
| 2006 | 6 | 1 | 7 |
| 2007 | 3 | 0 | 3 |
| 2008 | 7 | 1 | 8 |
| 2009 | 8 | 0 | 8 |
| 2010 | 4 | 1 | 5 |
| 2011 | 5 | 3 | 8 |
| 2012 | 4 | 1 | 5 |
| 2013 | 4 | 4 | 8 |
| 2014 | 6 | 3 | 9 |
| 2015 | 10 | 1 | 11 |
| 2016 | 3 | 4 | 7 |
| 2017 | 2 | 1 | 3 |
| 2018 | 6 | 2 | 8 |
| 2019 | 1 | 1 | 2 |
| 2020 | 7 | 2 | 9 |
| 2021 | 10 | 0 | 10 |
| 2022 | 12 | 1 | 13 |
Below are the most recent publications written about "Hemostatics" by people in Profiles.
-
Hemostatic and Thrombotic Considerations in the Diagnosis and Management of Childhood Arterial Ischemic Stroke: A Narrative Review. Semin Pediatr Neurol. 2022 10; 43:101003.
-
Whole-exome sequencing of 14?389 individuals from the ESP and CHARGE consortia identifies novel rare variation associated with hemostatic factors. Hum Mol Genet. 2022 09 10; 31(18):3120-3132.
-
Moderate-intensity aerobic exercise vs desmopressin in adolescent males with mild hemophilia A: a randomized trial. Blood. 2022 09 08; 140(10):1156-1166.
-
Transfusion Strategies for Hemostatic Blood Products in Critically Ill Children: A Narrative Review and Update on Expert Consensus Guidelines. Anesth Analg. 2022 09 01; 135(3):545-557.
-
Use of Cold-Stored Whole Blood is Associated With Improved Mortality in Hemostatic Resuscitation of Major Bleeding: A Multicenter Study. Ann Surg. 2022 10 01; 276(4):579-588.
-
Cerebral Microbleeds During Transcatheter Aortic Valve Replacement: A Prospective Magnetic Resonance Imaging Cohort. Circulation. 2022 Aug 02; 146(5):383-397.
-
Continuous Infusion of Factor VIII and von Willebrand Factor in Surgery: Trials with pdFVIII LFB or pdVWF LFB in Patients with Bleeding Disorders. Thromb Haemost. 2022 Aug; 122(8):1304-1313.
-
Percutaneous delivery of self-propelling thrombin-containing powder increases survival from noncompressible truncal hemorrhage in a swine model of coagulopathy and hypothermia. J Trauma Acute Care Surg. 2022 08 01; 93(2S Suppl 1):S86-S93.
-
Neutralizing Antibodies Against Factor VIII Can Occur Through a Non-Germinal Center Pathway. Front Immunol. 2022; 13:880829.
-
Pharmacokinetic analysis identifies a factor VIII immunogenicity threshold after AAV gene therapy in hemophilia A mice. Blood Adv. 2022 04 26; 6(8):2628-2645.